Skip to content

CBP EVOLUTION

Active
Private limited companyfounded 2019active for 7 yearsRue du Vivier 28, 1401 Nivelles, BelgiumKBO/BCE: BE 0722.882.107
Summary

CBP EVOLUTION has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €59,560 and a net result of €15,122. Equity is growing by about 20% per year across the filed financial years. Its solvency ranks better than 32% of 20,511 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Activity
Physiotherapy
NACE 86951
Size
€152,031total assets 2025
Equity
€59,560
Profit
€15,122
Turnover not published (micro format)
Financial health
91 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
Accounts 47 days early0 of 3 deeds read
Why 91raises riskNo registered site in the KBOlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 1.22, cash €34,736Figures for financial year 2025 (filed 14-06-2026)Show the evidence

Checked score

Score 2025
91 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 28% of its sector peers (NACE 86, micro)
Financial strength · tick = 2024
Strong
Solvency 64-8
equity 39.2% of total assets
Liquidity 59+11
short-term debt 40.8% · cash 22.8%
Profitability 81-11
return on assets 9.9%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,086 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024lowest value 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: 0.1%▲ +0.1 percentage points vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.1%● unchanged vs 11-2025 01-2026: 0.1%● unchanged vs 12-2025 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026highest value 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: < 0.1%▼ -0.1 percentage points vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €5,000 on 30-day terms is acceptable
Liquidity tight (current ratio 1.22, compared with 1.67 in 2024, below the usual 1.5; short-term debt: 40.8% and cash: 22.8% of total assets), and 60.8% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 32% on solvency, 36% on liquidity, 28% on profitability and 16% on growth.

The bankruptcy probability was computed on 20-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 1.22, cash €34,736
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 14-06-2026)
NBB · annual accounts
raises risk · No registered site in the KBO
KBO · seat and establishments
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 14-06-2026, 47 days ahead of the deadline.
NBB · 6 filings
Deviation from the deadline
2025
47 days early
2024
20 days late
2023
70 days early
2022
31 days late
2021
31 days late
2020
26 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 6 accounts on average 2 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 20 August (4 of the last 5 filed years within 67 days of that day).
Companies Code · seven months
Where today falls in the filing period
21-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Weakest financial yearnet €15,122 ▼59.9%
  3. Annual accounts filedfinancial year 2024 · micro…

Financials · financial year 2025, micro format

Turnover
€124,231▲ 2.9%
2021 · €120,743
EBIT margin
28.0%▲ 8.9pp
2021 · 19.1%
Net result
€15,122▼ 59.9%
2024 · €37,710
Working capital
€13,820▼ 73.5%
2024 · €52,123
Trend over the years

2021 to 2025, 5 financial years 2020 to 2025, 6 financial years

The operating result falls in 2025; 2025 is 57% below 2024.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Turnover€124,231 2022 Operating result€23,606 2025 Net result€15,122 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).

Every figure with its change against the financial year before
favourable unfavourable
Line202020212022202320242025
Turnover€368,615-€120,743▼ 67.2%€124,231▲ 2.9%
Operating result€38,751-€23,102▼ 40.4%€34,769▲ 50.5%€37,287▲ 7.2%€54,829▲ 47.0%€23,606▼ 56.9%
Net result€30,300within the sector's middle half-€16,094below the sector's middle half▼ 46.9%€25,627within the sector's middle half▲ 59.2%€34,227within the sector's middle half▲ 33.6%€37,710within the sector's middle half▲ 10.2%€15,122below the sector's middle half▼ 59.9%
EBIT margin10.5%-19.1%▲ 8.6pp28.0%▲ 8.9pp
Equity€38,380below the sector's middle half-€53,674below the sector's middle half▲ 39.8%€78,501within the sector's middle half▲ 46.3%€106,728within the sector's middle half▲ 36.0%€94,438within the sector's middle half▼ 11.5%€59,560within the sector's middle half▼ 36.9%
Total assets€259,804within the sector's middle half-€63,375below the sector's middle half▼ 75.6%€96,353below the sector's middle half▲ 52.0%€122,675below the sector's middle half▲ 27.3%€202,782within the sector's middle half▲ 65.3%€152,031within the sector's middle half▼ 25.0%
Debt€221,424-€9,701▼ 95.6%€17,852▲ 84.0%€15,947▼ 10.7%€108,344▲ 579%€92,471▼ 14.7%
Working capital-€49,951below the sector's middle half-€47,728within the sector's middle half€72,014within the sector's middle half▲ 50.9%€99,171within the sector's middle half▲ 37.7%€52,123within the sector's middle half▼ 47.4%€13,820within the sector's middle half▼ 73.5%
Solvency14.8%below the sector's middle half-84.7%above the sector's middle half▲ 69.9pp81.5%within the sector's middle half▼ 3.2pp87.0%above the sector's middle half▲ 5.5pp46.6%within the sector's middle half▼ 40.4pp39.2%within the sector's middle half▼ 7.4pp
Current ratio0.77below the sector's middle half-5.92within the sector's middle half▲ 5.155.88within the sector's middle half▼ 0.047.75above the sector's middle half▲ 1.871.67within the sector's middle half▼ 6.081.22within the sector's middle half▼ 0.45
Return on assets (ROA)11.7%within the sector's middle half-25.4%within the sector's middle half▲ 13.7pp26.6%within the sector's middle half▲ 1.2pp27.9%within the sector's middle half▲ 1.3pp18.6%within the sector's middle half▼ 9.3pp9.9%below the sector's middle half▼ 8.6pp
above within below the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €152,031
Fixed assets €76,136 ▲ 4.3%
Current assets €75,895 ▼ 41.5%
Equity and liabilities €152,031
Equity €59,560 ▼ 36.9%
Debt €92,471 ▼ 14.7%
Debt's share of the balance-sheet total rises from 53.4% to 60.8%. Equity and debt are lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€31,145▼
2024 · €61,108
Cash flow
€22,661▼
2024 · €43,989
Debt to equity
1.55▲
2024 · 1.15
ROE
25.4%▼
2024 · 39.9%
Interest coverage
9.43▼
2024 · 15.91
Debt ≤ 1 year
€62,075▼
2024 · €77,675
Debt > 1 year
€29,686=
2024 · €29,686
Income taxes
€5,180▼
2024 · €13,278
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 26,975 companies that looked in July 2024 the way this one looks now, 1.6% went bankrupt within 24 months and 94.9% are still going.

  • Micro
  • 5 to 10 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
1.6% went bankrupt
3.4% stopped otherwise
94.9% still going

A further 0.1% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a lower bankruptcy probability: < 0.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,473 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 26,975 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 42 lines
Balance sheet Code20242025
Assets
Total assets20/58€202,782€152,031▼
Fixed assets21/28€72,984€76,136▲
Tangible fixed assets22/27€72,984€76,136▲
Land and buildings22€50,107€48,554▼
Plant, machinery and equipment23€19,937€22,513▲
Furniture and vehicles24€2,940€5,069▲
Current assets29/58€129,798€75,895▼
Amounts receivable within one year40/41€102,868€37,757▼
Trade receivables40€42,868€33,937▼
Other amounts receivable41€60,000€3,820▼
Cash at bank and in hand54/58€25,428€34,736▲
Deferred charges and accrued income490/1€1,502€3,402▲
Equity and liabilities
Total equity and liabilities10/49€202,782€152,031▼
Equity10/15€94,438€59,560▼
Contributions10/11€8,080€8,080=
Profit (loss) carried forward14€86,358€51,480▼
Amounts payable17/49€108,344€92,471▼
Amounts payable after more than one year17€29,686€29,686=
Financial debts170/4€29,686€29,686=
Amounts payable within one year42/48€77,675€62,075▼
Current portion of amounts payable after more than one year42€10,793-
Trade debts44€1,336€993▼
Suppliers440/4€1,336€993▼
Taxes, remuneration and social security45€13,768€7,924▼
Taxes450/3€13,768€7,924▼
Other amounts payable47/48€51,778€53,158▲
Accrued charges and deferred income492/3€983€710▼
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€6,279€7,539▲
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€709-
Other operating charges640/8€7,878€10,375▲
Gross operating margin9900€69,695€41,520▼
Operating profit (loss)9901€54,829€23,606▼
Financial charges65/66B€3,841€3,304▼
Recurring financial charges65€3,841€3,304▼
Profit (loss) for the period before taxes9903€50,988€20,302▼
Income taxes67/77€13,278€5,180▼
Profit (loss) for the period9904€37,710€15,122▼
Profit (loss) for the period to be appropriated9905€37,710€15,122▼
Appropriation of the result
Profit (loss) to be appropriated9906€136,358€101,480▼
Profit (loss) brought forward from the previous period14P€98,648€86,358▼
Profit to be distributed694/7€50,000€50,000=
Return on contributions (dividend)694€50,000€50,000=

The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line202020212022202320242025Change
Turnover70€368,615€120,743€124,231----
Goods, raw materials, services and sundry goods60/61-€90,661€87,547----
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€29,009€2,886€3,827€3,952€6,279€7,539▲ 20.1%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4---€1,170€709--
Other operating charges640/8-€5,258€644€11,979€7,878€10,375▲ 31.7%
Gross operating margin9900€74,435€31,246€39,240€54,388€69,695€41,520▼ 40.4%
Operating profit (loss)9901€38,751€23,102€34,769€37,287€54,829€23,606▼ 56.9%
Financial income75/76B--€1€8,232---
Recurring financial income75€1,041-€1€8,232---
Financial charges65/66B-€2,088€2,974€2,390€3,841€3,304▼ 14.0%
Recurring financial charges65€249€2,088€2,974€2,390€3,841€3,304▼ 14.0%
Profit (loss) for the period before taxes9903€39,543€21,014€31,796€43,129€50,988€20,302▼ 60.2%
Income taxes67/77€9,243€4,920€6,169€8,902€13,278€5,180▼ 61.0%
Profit (loss) for the period9904€30,300€16,094€25,627€34,227€37,710€15,122▼ 59.9%
Profit (loss) for the period to be appropriated9905€30,300€16,094€25,627€34,227€37,710€15,122▼ 59.9%
Line202020212022202320242025Change
Assets
Total assets20/58€259,804€63,375€96,353€122,675€202,782€152,031▼ 25.0%
Fixed assets21/28€88,331€5,946€9,583€8,814€72,984€76,136▲ 4.3%
Tangible fixed assets22/27€88,331€5,946€9,583€8,814€72,984€76,136▲ 4.3%
Land and buildings22----€50,107€48,554▼ 3.1%
Plant, machinery and equipment23--€4,980€3,887€19,937€22,513▲ 12.9%
Furniture and vehicles24-€5,946€4,603€4,927€2,940€5,069▲ 72.4%
Current assets29/58€171,473€57,429€86,770€113,861€129,798€75,895▼ 41.5%
Stocks and contracts in progress3€7,701------
Amounts receivable within one year40/41€138,942€18,388€22,806€34,982€102,868€37,757▼ 63.3%
Trade receivables40-€15,736€15,193€30,708€42,868€33,937▼ 20.8%
Other amounts receivable41-€2,652€7,613€4,274€60,000€3,820▼ 93.6%
Current investments50/53--€29,750----
Cash at bank and in hand54/58€24,712€37,539€32,712€77,071€25,428€34,736▲ 36.6%
Deferred charges and accrued income490/1-€1,502€1,502€1,808€1,502€3,402▲ 126%
Equity and liabilities
Total equity and liabilities10/49€259,804€63,375€96,353€122,675€202,782€152,031▼ 25.0%
Equity10/15€38,380€53,674€78,501€106,728€94,438€59,560▼ 36.9%
Contributions10/11€8,080€8,080€8,080€8,080€8,080€8,080=
Contributions outside capital11-€8,080€8,080€8,080---
Share premium1100/10-€8,080€8,080€8,080---
Profit (loss) carried forward14€30,300€45,594€70,421€98,648€86,358€51,480▼ 40.4%
Amounts payable17/49€221,424€9,701€17,852€15,947€108,344€92,471▼ 14.7%
Amounts payable after more than one year17--€3,096€1,257€29,686€29,686=
Financial debts170/4--€3,096€1,257€29,686€29,686=
Amounts payable within one year42/48€221,424€9,701€14,756€14,690€77,675€62,075▼ 20.1%
Current portion of amounts payable after more than one year42--€1,783€2,672€10,793--
Trade debts44€111,620€2,581€2,045€3,679€1,336€993▼ 25.7%
Suppliers440/4-€2,581€2,045€3,679€1,336€993▼ 25.7%
Taxes, remuneration and social security45-€6,320€962€2,339€13,768€7,924▼ 42.4%
Taxes450/3-€6,320€962€2,339€13,768€7,924▼ 42.4%
Other amounts payable47/48-€800€9,966€6,000€51,778€53,158▲ 2.7%
Accrued charges and deferred income492/3----€983€710▼ 27.8%
Line202020212022202320242025Change
Profit (loss) for the period9904€30,300€16,094€25,627€34,227€37,710€15,122▼ 59.9%
+ Depreciation and write-downs630€29,009€2,886€3,827€3,952€6,279€7,539▲ 20.1%
Operating cash flow (approximation)€59,309€18,980€29,454€38,179€43,989€22,661▼ 48.5%
Investment in fixed assets (approximation)-€79,499-€7,464-€3,183-€70,449-€10,691▲ 84.8%
Change in cash-€12,827-€4,827€44,359-€51,643€9,308-

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Filings with the National Bank (6)
Financial year Type Filed Reference
31-12-2025 micro format 14-06-2026 2026-00174012
31-12-2024 micro format 20-08-2025 2025-00394622
31-12-2023 micro format 22-05-2024 2024-00095101
31-12-2022 micro format 31-08-2023 2023-00425711
31-12-2021 micro format 31-08-2022 2022-20418244
31-12-2020 micro format 26-08-2021 2021-55700397

Similar companies · same sector, comparable size

Of the 12,602 active companies whose main activity is physiotherapy (NACE 86951), figures are known for 2,244. 2,033 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
No directors read yet: 0 of 3 Gazette acts processed. See the directors and other office holders in the KBO →

Owners and capital

Owners

No owners or capital events in the accounts and acts we read.

History

CBP EVOLUTION was incorporated on 18 March 2019.1 Turnover fell from €368,615 in 2020 to €124,231 in 2022.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2020 and 2022

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
14-06
NBB filing Annual accounts filed
financial year 2025 · micro format
2025
31-12
Financial Weakest financial yearnet €15,122 ▼59.9%
Net result drops to €15,122, the lowest in the series.
20-08
NBB filing Annual accounts filed
financial year 2024 · micro format · 20 days late
2024
31-12
Financial Highest result from 2020 to 2025net €37,710 ▲10.2%
Operating result €54,829, net result €37,710, both a record.
22-05
NBB filing Annual accounts filed
financial year 2023 · micro format
2023
31-12
Financial Equity above €100,000equity €106,728 ▲36%
A profit in every financial year since 2020 builds equity to €106,728.
31-08
NBB filing Annual accounts filed
financial year 2022 · micro format · 31 days late
2022
31-08
NBB filing Annual accounts filed
financial year 2021 · micro format · 31 days late
2021
31-12
Financial Liquidity more than 7 timescurrent ratio 5.92
Current ratio from 0.77 to 5.92; short-term debt falls from €221,424 to €9,701.
26-08
NBB filing Annual accounts filed
financial year 2020 · micro format · 26 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 3 deeds read
About the unread acts

We know of 3 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Register details

Identification
Legal formPrivate limited company
Founded18-03-2019
Financial year end31-12
Activities, NACEBEL 2025
86951Physiotherapy
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
E-invoicing
Reachable via Peppol
Peppol ID 0208:0722882107
Registered 27-03-2026

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 20 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Recognitions · licences · registrations

Legal Entity Identifier

875500HGWBNXW85HQ431
live in the LEI register

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Nivelles
exact location from the address register On OpenStreetMap
Ground area
503 m²
Building footprint
110 m²
Building volume
554 m³
Parcel 25004E0174/00Y011, Wallonia · tallest building 7.1 m. Linked by address, not a title deed.
2 companies at this address See who is registered here
1 parcel
Wallonia 1 (100%)
Cadastral parcel Region Area Buildings Height / floors
25004E0174/00Y011 Wallonia 503 m² 1 · 110 m² 7.1 m · 2
How the parcels are linked
Good to know
The parcel matches the address exactly.